Laercio DaSilva, MD is a medical oncologist who specializes in caring for patients with lung cancer, thymic tumors and mesothelioma. His practice is based at Winship Cancer Institute at Emory Midtown and Grady Memorial Hospital. In addition to his clinical practice, Dr. DaSilva is actively engaged in research focusing on the development of early-phase clinical trials and immunotherapy for thoracic tumors.
Dr. DaSilva is an assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine.
He earned his medical degree from the Faculdade de Ciências Médicas da Santa Casa de São Paulo in Brazil. He completed his internal medicine residency at Irmandade Santa Casa de Misericórdia de São Paulo in Brazil and MetroWest Medical Center/Tufts University School of Medicine in Framingham, Massachusetts. He subsequently completed his medical oncology fellowship at the National Cancer Institute in Bethesda, Maryland where he served as chief fellow in his final year.
Titles & Roles
Assistant Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Education & Training
Education
Fellowship, Medical Oncology, 2025
National Cancer Institute
Fellowship, Hematology/Oncology, 2024
National Cancer Institute
Residency, Internal Medicine, 2022
Metrowest Medical Center
Internship, Internal Medicine, 2020
Metrowest Medical Center
Medical Education, MD, 2014
Facultad de Ciencias Medicas de La - Buenos Aires
Board Certifications
Internal Medicine
American Board of Internal Medicine, 2026
Professional Memberships
Society for Immunotherapy of Cancer
American Association for Cancer Research
American Society of Hematology
International Association for the Study of Lung Cancer
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
